The novel approach of this peptide represents a exciting development in the management of type 2 diabetes. Distinct from existing therapies, tirzepatide affects multiple pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide106468.prublogger.com/40827408/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment